Drug Trial Radar · NCT05055934
Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis
Last checked: Nov 19, 2026Latest source record: Dec 12, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
112
Actual
Start
Oct 22, 2021
Primary completion
Jun 5, 2024
Study completion Jun 5, 2024
Sponsor
- Lead sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 24, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a randomized, double-blind, multicenter, placebo-controlled Phase II clinical study, consisting of a 4-week screening period, a 12-week core treatment period, a 12-week maintenance treatment period, and an 8-week safety follow-up period. It is planned to include 111 adult subjects with psoriatic arthritis.
Conditions
- Psoriatic Arthritis
Interventions
SHR-1314 injectionDrug
SHR-1314 injection
placeboDrug
placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of subjects achieving ACR 20 improvement at week 12Time frame: at week 12
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Huashan Hospital of the Shanghai FuDan University
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.